Wilson Sonsini Goodrich & Rosati advised Logos Capital on the deal while Sidley represented Attralus, Inc. Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines...
Attralus’ $116 Million Series B Financing
Century Therapeutics’ $160-million Series C Financing
Brown Rudnick LLP advised lead investor Casdin Capital and a syndicate of new investors, while White & Case LLP advised Qatar Investment Authority on the deal....
Vividion Therapeutics’ $135 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised Vividion Therapeutics, Inc. and the lead investors on the deal. Vividion Therapeutics, Inc., a biotechnology company utilizing novel discovery technologies...